Sebastian Köhler Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2023	The association of prediabetes and type 2 diabetes with hippocampal subfields volume: The Maastricht study.
1/2022	Health burden in type 2 diabetes and prediabetes in The Maastricht Study.
11/2021	Associations between plasma kynurenines and cognitive function in individuals with normal glucose metabolism, prediabetes and type 2 diabetes: the Maastricht Study.
1/2020	Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.
1/2018	A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes.
1/2017	Replacement Effects of Sedentary Time on Metabolic Outcomes: The Maastricht Study.
8/2015	Both Low and High 24-Hour Diastolic Blood Pressure Are Associated With Worse Cognitive Performance in Type 2 Diabetes: The Maastricht Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sebastian Köhler Research Topics

Disease

14	Cognitive Dysfunction 11/2023 - 02/2010
13	Stroke (Strokes) 04/2024 - 08/2013
12	Dementia (Dementias) 12/2023 - 01/2015
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2015
6	Hypertension (High Blood Pressure) 04/2024 - 02/2014
6	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 05/2015
5	Albuminuria 11/2021 - 01/2017
4	Atrial Fibrillation 04/2024 - 01/2019
4	Prediabetic State (Prediabetes) 01/2023 - 11/2021
3	Ischemic Stroke 04/2024 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2015
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2024 - 01/2023
2	Neurobehavioral Manifestations 12/2023 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2017
2	Diabetes Mellitus 01/2021 - 01/2020
2	Cerebral Small Vessel Diseases 01/2020 - 01/2020
2	Undiagnosed Diseases 01/2019 - 01/2016
2	Intellectual Disability (Idiocy) 01/2018 - 10/2010
2	Atrophy 05/2016 - 02/2010
1	Transient Ischemic Attack 04/2024
1	Heart Diseases (Heart Disease) 12/2023
1	Hypoglycemia (Reactive Hypoglycemia) 12/2023
1	Orthostatic Hypotension (Postural Hypotension) 12/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2023
1	Vitamin D Deficiency 12/2023
1	Hearing Loss (Hearing Impairment) 12/2023
1	Delirium 12/2023
1	Rheumatoid Arthritis 12/2023
1	Alcoholism (Alcohol Abuse) 12/2023
1	Ganglion Cysts (Ganglion) 08/2023
1	Hematologic Diseases (Blood Diseases) 03/2023
1	Infections 01/2022
1	COVID-19 01/2022
1	Glucose Intolerance 11/2021
1	Infarction (Infarctions) 01/2021
1	Insulin Resistance 11/2020
1	Frontotemporal Dementia (Semantic Dementia) 03/2020
1	Inflammation (Inflammations) 01/2020
1	Hyperemia 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Brain Injuries (Brain Injury) 01/2018
1	Multiple Sclerosis 01/2018

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 08/2023 - 05/2015
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
5	CholesterolIBA 01/2022 - 01/2015
5	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2010
3	ApolipoproteinsIBA 12/2023 - 01/2019
3	Retinaldehyde (Retinal)IBA 08/2023 - 01/2020
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2017
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 02/2014
2	AnticoagulantsIBA 04/2024 - 01/2023
2	AlbuminsIBA 12/2023 - 01/2018
2	KynurenineIBA 11/2023 - 11/2021
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	LipidsIBA 01/2020 - 08/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 05/2015
2	Alkaline PhosphataseIBA 01/2018 - 10/2010
2	Cystatin CIBA 01/2018 - 01/2017
2	CreatinineIBA 01/2018 - 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024
1	Nitrogen OxidesIBA 12/2023
1	C-Reactive ProteinIBA 12/2023
1	Vitamin D FDA LinkGeneric 12/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023
1	PesticidesIBA 12/2023
1	BenzodiazepinesIBA 12/2023
1	Particulate MatterIBA 12/2023
1	Tryptophan (L-Tryptophan)FDA Link 11/2023
1	CeramidesIBA 07/2023
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	Vitamin K FDA Link 01/2023
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	xanthurenic acidIBA 11/2021
1	Kynurenic Acid (Kynurenate)IBA 11/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021
1	3-Hydroxyanthranilic AcidIBA 11/2021
1	3-hydroxykynurenineIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	HDL CholesterolIBA 01/2020
1	DiureticsIBA 01/2020
1	SelectinsIBA 01/2020
1	E-SelectinIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	von Willebrand FactorIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	CarbohydratesIBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018
1	EnzymesIBA 01/2018

Therapy/Procedure

3	Therapeutics 04/2024 - 01/2021
3	Activities of Daily Living (ADL) 12/2023 - 01/2018
2	Secondary Prevention 04/2024 - 01/2018
1	Precision Medicine 04/2023
1	Hematopoietic Stem Cell Transplantation 03/2023
1	Patient Care 12/2022
1	Cognitive Training 01/2020